Elevance Health, Inc.
ELV- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001156039
In the last 90 days, Elevance Health, Inc. insiders filed 0 open-market purchases and 2 sales; 1,620 institutions reported holding it in 13F filings for Q2 2026, worth $76.8B in total; superinvestors Harris Associates (Oakmark) and Baupost Group hold it.
Key figures
- Market capClose on Nov 9, 2026
- $90.4B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $5.23M in total
- 2
- 13F holdersQ2 2026, +160 vs. previous quarter
- 1,620
- 13F valueReported value at the end of Q2 2026
- $76.8B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $199.1B
- +12.5% year over year
- Net income, FY2025
- $5.66B
- −5.3% year over year
- Free cash flow, FY2025
- $3.17B
- −30.3% year over year
- Revenue, Q3 FY2026
- $51.4B
- +1.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 5.14M
- Shares sold short
- Change
- +283.0K
- +5.8% vs. previous
- Days to cover
- 4.00
- At average daily volume
Superinvestors holding ELV, Q2 2026
Go to the superinvestors tab2 superinvestors report holding Elevance Health, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Harris Associates (Oakmark)
Bill Nygren
2.5%
Elevance Health, Inc.'s share of the portfolio
- Shares
- 4,924,511
- Value
- $1.90B
Baupost Group
Seth Klarman
9.1%
Elevance Health, Inc.'s share of the portfolio
- Shares
- 1,275,154
- Value
- $493.1M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Elevance Health, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 (view filing)4:32 PM ET | Nov 5 | 1 day | Lavu RatnakarEVP & Chief Digital Info Ofr | SSale | −1.30K | $440.00 | −$572.0K | −8.1%14.8K after | |
| Oct 23, 2026 (view filing)4:30 PM ET | Oct 22 | 1 day | Kaye MarkEVP & CFO | SSale | −10.6K | $440.13 | −$4.66M | −34.7%19.9K after | 13 lots |
| Jul 17, 2026 (view filing)3:04 PM ET | Jul 17 | Same day | Peru Ramiro GDirector | PPurchase | +1.00K | $366.05 | +$366.1K | +10.1%10.9K after | |
| Jul 17, 2026 (view filing)1:50 PM ET | Jul 17 | Same day | Boudreaux GailPresident and CEO | PPurchase | +2.73K | $367.79 | +$1.00M | +1.6%172.0K after | 2 lots |
| Jun 15, 2026 (view filing) | Jun 12 | 3 days | Penczek Ronald WCAO & Controller | SSale | −369 | $403.16 | −$148.8K | −9.0%3.74K after | |
| Jun 12, 2026 (view filing) | Jun 11 | 1 day | Dixon Robert L JRDirector | SSale | −151 | $401.77 | −$60.7K | −1.4%10.7K after | |
| May 20, 2026 (view filing) | May 19 | 1 day | Penczek Ronald WCAO & Controller | SSale | −1.53K | $403.13 | −$617.2K | −27.1%4.11K after | |
| Mar 23, 2026 (view filing) | Mar 12 | 11 daysLate | Schulman Amy WDirector | SSale | −26 | $287.50 | −$7.47K | −10.7%218 after | |
| Mar 9, 2026 (view filing) | Mar 6 | 3 days | Kendrick Charles Morgan JREVP & President, Commercial | SSale | −3.20K | $284.92 | −$910.6K | −21.3%11.8K after | |
| Mar 6, 2026 (view filing) | Mar 5 | 1 day | Collis Steven HDirector | PPurchase | +3.00K | $289.84 | +$869.5K | +469.5%3.64K after |
Top 10 13F holders, Q2 2026
See all 1,620 holdersThe largest institutional positions in Elevance Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18,991,090 | $7.34B | 0.11% | −896,021−4.5% | Reduced |
| Vanguard Capital Management LLC | 14,058,204 | $5.44B | 0.12% | −287,255−2.0% | Reduced |
| State Street Corp | 10,426,610 | $4.03B | 0.12% | +137,914+1.3% | Added |
| Wellington Management Group LLP | 9,213,513 | $3.56B | 0.61% | +984,976+12.0% | Added |
| Vanguard Portfolio Management LLC | 6,214,356 | $2.40B | 0.11% | −141,721−2.2% | Reduced |
| Sanders Capital, LLC | 5,825,024 | $2.25B | 2.26% | −69,279−1.2% | Reduced |
| Geode Capital Management, LLC | 5,166,124 | $1.99B | 0.11% | −26,583−0.5% | Reduced |
| Harris Associates L PSuperinvestorHarris Associates (Oakmark) | 4,924,511 | $1.90B | 2.53% | +127,985+2.7% | Added |
| Artisan Partners Limited Partnership | 4,581,222 | $1.77B | 2.89% | −545,953−10.6% | Reduced |
| Invesco Ltd. | 4,234,231 | $1.64B | 0.13% | −583,179−12.1% | Reduced |
Holders of 5% or more of ELV
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Elevance Health, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.80%17.7M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 7.13%16.6M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Politician trades
All politician trades in ELV20 members of Congress reported 54 trades in Elevance Health, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
| Jan 16, 2026 |  Markwayne Mullin Senate · OK | Buy | $15K-$50K |
| Sep 12, 2025 |  Val T. Hoyle House · OR | Buy | $1K-$15K |
| Sep 12, 2025 | Val T. Hoyle House · OR | Sell | $1K-$15K |
| Sep 12, 2025 |  Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
Senate · OK · Jul 21, 2026
Buy$1K-$15K
Senate · OK · Jan 16, 2026
Buy$15K-$50K
House · OR · Sep 12, 2025
Buy$1K-$15K
House · OR · Sep 12, 2025
Sell$1K-$15K
House · CA · Sep 12, 2025
Buy$1K-$15K